BioMed Central Investigates Association of Proton Pump Inhibitors with Chronic Kidney Disease

Posted by Firm Staff on Mar 28, 2017 3:15:36 PM
Find me on:

PPI_0317_fandhlaw.jpegProton pump inhibitors (PPIs) used to treat heartburn have been linked to an increased risk of developing kidney disease. In this post we discuss research conducted by BioMed Central that investigates the associated risks of PPIs.


According to the study, proton pump inhibitors first became available to the US in 1989. Since then PPIs such as Nexium and Prevacid have become one of the most widely prescribed classes of drugs to treat gastro-esophageal reflux disease (GERD).


At the end of the study, BioMed Central concludes that long-term use of proton pump inhibitors for heartburn is associated with increased risk of development of chronic kidney disease and even death. In fact, it’s stated that PPI use increased the odds of chronic kidney disease development by 10%.


If you or a loved one has taken a PPI such as Nexium, Prilosec, or Prevacid, it’s important to be aware of the potential effects and your rights. Consult with your physician if you have medical concerns. To help you stay informed, The Law Offices of Foster & Houston will continue to share important news involving these heartburn drugs.


If you’ve taken PPIs and have experienced kidney disease, you may be able to obtain compensation for your injury. You can learn more about seeking justice and GERD drugs by visiting our website.


Sources: BioMed Central


Additional Proton-Pump Inhibitor Resources:

Topics: Health News, Heartburn, Kidney Disease, Kidney Damage, The Law Offices of Foster & Houston, Nexium, FANDHLAW, Nexium Lawsuit, Prilosec, PPI, PPI Lawsuit, Heartburn Drug Lawsuit, Ryan Foster, Foster & Houston, Heartburn Drugs, Prilosec Lawsuit, GERD Drug, GERD Drugs, GERD Drug Lawsuit, Prevacid, Heartburn Drug, Chronic Kidney Disease, Kidney Failure, Prevacid Lawsuit

Contact Foster & Houston

More to Read